NATCO PHARMA LTD
BSE:​NATCOPHARM

 
     
 
     
Prev
 
Open
 
Volume
 
1 Day Range
  -  
EPS
 
Mkt Cap
 
PE
 
Div Yield
 
Popular Today
Popular Today
Popular All Time
Newest
Charts and Videos
Charts and Videos
Charts
Videos

NATCOPHARM Stock Chart

 

Technical Analysis Summary

NATCOPHARM

NATCOPHARM Financials

Price History
Average Volume (10 day) ---
Beta - 1 Year ---
Price - 52 Week High ---
Price - 52 Week Low ---
Valuation
Enterprise Value/EBITDA, TTM ---
Enterprise Value, FQ ---
Market Cap - Basic ---
Number of Employees ---
Number of Shareholders ---
Price/Earnings, TTM ---
Price/Revenue, TTM ---
Price/Book Ratio, FY ---
Price/Sales Ratio, FY ---
Dividends
Dividends Paid, FY ---
Dividends per Share, FQ ---
Expected Annual Dividends ---
Dividends Yield ---
Margins
Net Margin, TTM ---
Gross Margin, TTM ---
Operating Margin, TTM ---
Pretax Margin, TTM ---
Balance Sheet
Cash Ratio, FY ---
Current Ratio, FQ ---
Debt to Equity, FQ ---
Net Debt, FQ ---
Quick Ratio, FQ ---
Total Assets, FQ ---
Total Debt, FQ ---
Income Statement
Basic EPS, Net Income ---
Earnings per Share, Basic, TTM ---
EBITDA, TTM ---
Gross Profit, FY ---
Last Annual EPS ---
Last Annual Revenue, FY ---
Net Income, FY ---
Total Revenue, FY ---
Free Cash Flow, TTM ---
Operating Metrics
Return on Assets, TTM ---
Return on Equity, TTM ---
Return on Invested Capital, TTM ---
Revenue per Employee, TTM ---

News

mightyrajat mightyrajat NATCOPHARM, 1W, Long ,
NATCOPHARM: natco pharma- a long term investment bet
41 0 0
NATCOPHARM, 1W Long
natco pharma- a long term investment bet

Fundamentally a strong company. shall be invested with a long term view. shall see 1050 in near term and might be a 2x candidate if held patiently for a couple of years. happy investing.

GagandeepSinghTaluja GagandeepSinghTaluja NATCOPHARM, W, Long ,
NATCOPHARM: Natco Pharma
45 0 2
NATCOPHARM, W Long
Natco Pharma

Fundamentals- 1)Excellent company with excellent fundamentals. 2)Expanding at very high rate. around 20% YoY basis. 3)Excellent numbers like operating profit, very good valuation with peers within the sector. 4)Awesome sales and profit figures. 5) Recently entered into the the medicines for Oncology 6)One of the very few pharmaceutical companies to manufacture ...

narendkadam narendkadam NATCOPHARM, W,
NATCOPHARM: NATCO PHARMA
32 0 1
NATCOPHARM, W
NATCO PHARMA

The information is for educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced by me. The information provided through my charts is for personal, non-commercial, educational use and display.

EN English (IN)
EN English
EN English (UK)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
AR العربية
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out
Browse
Video